Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

The rapid corticotropin test is a quick and simple way to diagnose adrenal insufficiency.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

High doses of TCB cause severe health issues in marmoset monkeys.

Propylthiouracil treatment can cause hair loss.

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

G-CSF effectively treated a teenager's cyclic neutropenia and reduced her symptoms without adverse effects.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Temporary facial blanching can occur after Botulinum toxin injections, but it resolves without discomfort.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Pertussis toxin may contribute to hair loss in alopecia areata.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Sintilimab treatment caused hair loss but led to complete tumor remission.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Imbalance in immune cells causes hair loss in alopecia areata.